Skip to content
← Back to this collection

PUBLICATIONS · 20658611

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2010 Sep
First author
Gorman MF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gorman MF
      type
      Author
    2. name
      Ji L
      type
      Author
    3. name
      Ko RH
      type
      Author
    4. name
      Barnette P
      type
      Author
    5. name
      Bostrom B
      type
      Author
    6. name
      Hutchinson R
      type
      Author
    7. name
      Raetz E
      type
      Author
    8. name
      Seibel NL
      type
      Author
    9. name
      Twist CJ
      type
      Author
    10. name
      Eckroth E
      type
      Author
    11. name
      Sposto R
      type
      Author
    12. name
      Gaynon PS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gorman MF
      type
      Author
    2. name
      Ji L
      type
      Author
    3. name
      Ko RH
      type
      Author
    4. name
      Barnette P
      type
      Author
    5. name
      Bostrom B
      type
      Author
    6. name
      Hutchinson R
      type
      Author
    7. name
      Raetz E
      type
      Author
    8. name
      Seibel NL
      type
      Author
    9. name
      Twist CJ
      type
      Author
    10. name
      Eckroth E
      type
      Author
    11. name
      Sposto R
      type
      Author
    12. name
      Gaynon PS
      type
      Author
    bibliography ids
    1. nci-bib-25acea220314d805fb8ed2e1
    book metadata
    content sha256
    928caafffcd43b9fe42e2ef1ab7cb04911a18ac3b23fcc3ca0768264f237b1b1
    document type
    citation
    dois
    1. 10.1002/pbc.22612
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20658611
    immutable id
    pubmed:20658611@928caafffcd43b9fe42e2ef1ab7cb04911a18ac3b23fcc3ca0768264f237b1b1
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    3
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    421-9
    volume
    55
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20658611
      provenance
      batch id
      10a38257e12e9ed1867a
      provider
      NCBI PubMed ESummary
      record sha256
      4027b776f844cd307ba2aaca4373258ddc3b044e4452193e3962dd777fed0b45
      response sha256
      84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
      retrieved at
      2026-09-09T23:46:35.793530+00:00
      publication date
      display
      2010 Sep
      precision
      month
      year
      2010
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20658611/
      title
      Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

      Preserved source evidence · Not medical advice